The Future of Endoscopic Retrograde Cholangiopancreatography in Korea

摘要

Although the advance of noninvasive imaging tests, such as magnetic resonance cholangiopancreatography and endoscopic ultrasonography, has replaced the diagnostic role of endoscopic retrograde cholangiopancreatography (ERCP), ERCP is still an important procedure in the non- surgical management of various pancreatobiliary diseases. During the past four decades since the first introduction in 1968, tremendous progress has been made in the equip- ment and technology of ERCP from fiberoptic endoscopes to high-resolution video duodenoscopes with additional devices. While ERCP performance is progressively trans- forming to a platform for more complex advanced tech- niques, such as cholangioscopy and ERCP in altered anat- omy, ERCP is still one of the most technically demanding endoscopic procedures, with thorough training and a steep learning curve in both technical endoscopic skills and judgement/interpretation and relatively high adverse event rates, ranging from 3% to 15%.